Category Archives: Tysabri

Featured Stories

Zadroga Act Cancer Decision Expected This Week

The federal official tasked with determining what ailments should be covered by the federal Zadroga Act is expected to decide by Saturday if certain cancers will be eligible for compensation. The decision is being eagerly awaited by thousands of first responders who believe they developed cancer due to exposure ...

Read More

Crash on N.State Pkwy Kills Port Jefferson Station Man

Single-Car Crash on Northern State Parkway Kills Port Jefferson Station Man

81-year-old Port Jefferson Station man was killed in a crash at 4:57 a.m.. He lost control of the vehicle traveling west on Northern State Pkwy, on exit 42, Dix Hills.

Read More

Post -Tonsillectomy Morphine Life-Threatening in Children

Post -Tonsillectomy Morphine can be Life-Threatening in Children, Study Finds

A new study published in Pediatrics suggests that morphine can result in life-threatening respiratory problems when given to children after a tonsillectomy.

Read More

FDA Advisors Set to Examine Metal-on-Metal Hip Implant Safety Concerns

Thousands of people with metal-on-metal hip implant devices could soon get some answers from the U.S. Food & Drug Administration (FDA) about the dangers they face. Tomorrow, the agency will convene a panel of outside medical experts to examine the safety record of metal-on-metal hip replacements, and recommend the ...

Read More

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Federal DePuy ASR Hip Implant Trials Likely to Start This Year

It looks as though the first trials in the DePuy ASR hip implant multidistrict litigation could begin sometime later this year. According to a report from Bloomberg News, during a status conference held yesterday in Florida, attorneys for both plaintiffs and the defense told U.S. District Judge David Katz that ...

Read More

Do Vitamin Drinks Pose Health Risks?Do Vitamin Drinks Pose Health Risks?

Do Vitamin Drinks Pose Health Risks?

Scientists are concerned vitamin drinks are contributing to levels of vitamins and other nutrients that are not only unnecessary, but potentially harmful.

Read More

Exposure to Common Pesticide May Increase ADHD Risk

Exposure to Common Pesticide May Increase ADHD Risk

A new study has found that exposure to a common household pesticide may increase the risk of attention deficit hyperactivity disorder (ADHD) in children.

Read More

Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent

Yet another study is confirming the association between the diabetes drug, Actos, and bladder cancer. This latest research, published today in the Canadian Medical Association Journal, found that taking Actos raised the risk of bladder cancer among diabetics by about one-fifth.

Read More

New Research Links Multiple Sclerosis Drug Tysabri to Fatal Brain Infection

A newly published report indicates that patients taking the multiple sclerosis drug Tysabri have a higher risk of developing a potentially fatal brain infection than previously thought. German and French researchers found that Tysabri (natalizumab), used to treat patients with … Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals, Tysabri |

Anti-Drug Antibodies Allegedly Lead to MS Patient’s Death

A Swedish woman diagnosed with multiple sclerosis (MS) appears to have died after developing anti-Tysabri (natalizumab) antibodies, according to emerging research. The woman tested with what MedPage Today described as “significant neurological abnormalities” and very high titers of antibodies against … Continue reading

Posted in Pharmaceuticals, Tysabri |

New Tysabri PML Risk Factor Identified

The Food and Drug Administration has identified a new risk factor which could lead to the life-threatening brain infection known as progressive multifocal leukoencephalopathy (PML) associated with the use of the drug Tysabri. Tysabri is prescribed as a “last resort” … Continue reading

Posted in Pharmaceuticals, Tysabri |

FDA Announces Tysabri Label Update

Last week, the U.S. Food & Drug Administration (FDA) announced it was updating the label of < "http://www.yourlawyer.com/topics/overview/tysabri">Tysabri (natalizumab) to include additional information about the risk of progressive multifocal leukoencephalopathy (PML), a rare but serious brain infection. According to a … Continue reading

Posted in Pharmaceuticals, Tysabri |

Tysabri Label Modified to Include More Brain Infection Data

< "http://www.yourlawyer.com/topics/overview/tysabri">Tysabri, the multiple sclerosis drug marketed by Biogen Idec Inc. and Elan Corp is having its label updated to include new data about the incidence of progressive multifocal leukoencephalopathy, or PML, a rare brain infection. According to a report … Continue reading

Posted in Tysabri |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.